These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34850893)

  • 1. Cannabinoids and Cancer Chemotherapy-Associated Adverse Effects.
    Ward SJ; Lichtman AH; Piomelli D; Parker LA
    J Natl Cancer Inst Monogr; 2021 Nov; 2021(58):78-85. PubMed ID: 34850893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis for cancer - illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology.
    Turgeman I; Bar-Sela G
    Expert Opin Investig Drugs; 2019 Mar; 28(3):285-296. PubMed ID: 30572744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis.
    Chow R; Valdez C; Chow N; Zhang D; Im J; Sodhi E; Lock M
    Support Care Cancer; 2020 May; 28(5):2095-2103. PubMed ID: 31916006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis.
    Slatkin NE
    J Support Oncol; 2007 May; 5(5 Suppl 3):1-9. PubMed ID: 17566383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.
    Davis MP
    Expert Opin Investig Drugs; 2008 Jan; 17(1):85-95. PubMed ID: 18095921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Established and potential therapeutic applications of cannabinoids in oncology.
    Walsh D; Nelson KA; Mahmoud FA
    Support Care Cancer; 2003 Mar; 11(3):137-43. PubMed ID: 12618922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Cannabis and Cannabinoids in Patients With Cancer.
    Sawtelle L; Holle LM
    Ann Pharmacother; 2021 Jul; 55(7):870-890. PubMed ID: 33070617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis in cancer care.
    Abrams DI; Guzman M
    Clin Pharmacol Ther; 2015 Jun; 97(6):575-86. PubMed ID: 25777363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cannabis and cannabinoids-easier access, hype and disappointment : What has been confirmed in therapy?].
    Rasche T; Emmert D; Stieber C; Conrad R; Mücke M
    Internist (Berl); 2019 Mar; 60(3):309-314. PubMed ID: 30680416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management.
    Shah SA; Gupta AS; Kumar P
    J Cancer Res Ther; 2021; 17(1):1-9. PubMed ID: 33723124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nabilone therapy for cannabis withdrawal presenting as protracted nausea and vomiting.
    Lam PW; Frost DW
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25246463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case Report on Cannabinoid Hyperemesis Syndrome in Palliative Care: How Good Intentions Can Go Wrong.
    Senderovich H; Waicus S
    Oncol Res Treat; 2022; 45(7-8):438-443. PubMed ID: 35504245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review.
    Tramèr MR; Carroll D; Campbell FA; Reynolds DJ; Moore RA; McQuay HJ
    BMJ; 2001 Jul; 323(7303):16-21. PubMed ID: 11440936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids: the lows and the highs of chemotherapy-induced nausea and vomiting.
    Mortimer TL; Mabin T; Engelbrecht AM
    Future Oncol; 2019 Mar; 15(9):1035-1049. PubMed ID: 30720344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of cannabinoids in counteracting chemotherapy-induced adverse effects: an exploratory review.
    Ostadhadi S; Rahmatollahi M; Dehpour AR; Rahimian R
    Phytother Res; 2015 Mar; 29(3):332-8. PubMed ID: 25504799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic potential of cannabis and cannabinoids.
    Grotenhermen F; Müller-Vahl K
    Dtsch Arztebl Int; 2012 Jul; 109(29-30):495-501. PubMed ID: 23008748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapeutic Considerations for Use of Cannabinoids to Relieve Symptoms of Nausea and Vomiting Induced by Chemotherapy.
    Serafimovska T; Darkovska-Serafimovska M; Stefkov G; Arsova-Sarafinovska Z; Balkanov T
    Folia Med (Plovdiv); 2020 Dec; 62(4):668-678. PubMed ID: 33415919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis.
    Machado Rocha FC; Stéfano SC; De Cássia Haiek R; Rosa Oliveira LM; Da Silveira DX
    Eur J Cancer Care (Engl); 2008 Sep; 17(5):431-43. PubMed ID: 18625004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting.
    Pergolizzi JV; Taylor R; LeQuang JA; Zampogna G; Raffa RB
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):467-477. PubMed ID: 28235999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.